-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Hemophilia B is a recessive genetic disease caused by the lack of coagulation factor FIX on the X chromosome.
In the course of its treatment, the formation of anti-drug antibodies (ADA) is one of the main problems that are difficult to overcome.
Because many drugs that promote blood coagulation often antagonize FIX in inappropriate organs and periods, and cause allergic reactions, scientists have tried a variety of techniques for a long time in the past, but have not yet found a suitable solution.
Program.
In recent years, through genetic engineering, scientists have begun to use plant cells to develop and express medical supplies.
For example, eating peanuts expressing anti-allergic agents can prevent peanut allergies.
In addition, some hospitals have begun to adopt treatment plans that use plant cells to express drug molecules for initial intervention.
Therefore, expressing the coagulation factor FIX in plants and fusing with appropriate transporters to release them in appropriate organs and timing is a potential solution for the treatment of hemophilia B.
Henry Daniell's team from Pennsylvania State University has long been engaged in the creation of a heterologous protein expression system for plant cells.
In the early stage, they successfully developed an oral preparation of plant cells that can treat animal hemophilia through chloroplast transformation.
Recently, they successfully created a lettuce that can express FIX without antibiotic markers.
Figure 1: Creation of expression vector without resistance marker and transgenic progeny (because the 5'and 3'of the resistance marker expression element can be recombined into a loop, it will be cleared after recombination) The FIX expressed in this lettuce is fused The transport factor CTB (cholera toxin B subunit) can perform protein cleavage and function in the body at the right time.
Due to the use of the optimal chloroplast transformation system and expression vector, the copy number of the FIX-CTB fragment is very high in lettuce leaves, making it possible for stable protein expression in both T1 and T2 generation plants (Figure 1).
After testing, the content of the target protein can reach 1.
0-1.
5 mg per 1 gram of freeze-dried leaves.
Figure 2: The trial and prospect of clinical application of plant cell drug products are further.
They used freeze-dried leaves to feed SD rats, with the content ranging from 0.
25mg/kg to 2.
5mg/kg, and no toxicity and allergic reactions were found.
The feeding experiment of beagle dogs also showed no obvious toxicity and allergic reactions, indicating that taking the plant cells expressing the drugs can effectively avoid allergic reactions caused by the direct use of drugs, and has a great promotion effect on the treatment of hemophilia B ( figure 2).
Original link: https://onlinelibrary.
wiley.
com/doi/epdf/10.
1111/pbi.
13608 Plant Biotechnology Pbj Exchange Group In order to more effectively help the majority of scientific researchers to obtain relevant information, Plant Biotechnology Pbj has established a WeChat Groups, Plant Biotechnology Journal submissions and document-related questions, public account release content and public account submission questions will be concentrated in the group for answers, while encouraging academic exchanges and collision thinking within the group.
In order to ensure a good discussion environment in the group, please add the editor WeChat first, scan the QR code to add, and then we will promptly invite you to join the group.
Tips: When adding the editor WeChat and after joining the group, please be sure to note the school or unit + name, and the PI should be noted at the end, and we will invite you to join the PI group.
In the course of its treatment, the formation of anti-drug antibodies (ADA) is one of the main problems that are difficult to overcome.
Because many drugs that promote blood coagulation often antagonize FIX in inappropriate organs and periods, and cause allergic reactions, scientists have tried a variety of techniques for a long time in the past, but have not yet found a suitable solution.
Program.
In recent years, through genetic engineering, scientists have begun to use plant cells to develop and express medical supplies.
For example, eating peanuts expressing anti-allergic agents can prevent peanut allergies.
In addition, some hospitals have begun to adopt treatment plans that use plant cells to express drug molecules for initial intervention.
Therefore, expressing the coagulation factor FIX in plants and fusing with appropriate transporters to release them in appropriate organs and timing is a potential solution for the treatment of hemophilia B.
Henry Daniell's team from Pennsylvania State University has long been engaged in the creation of a heterologous protein expression system for plant cells.
In the early stage, they successfully developed an oral preparation of plant cells that can treat animal hemophilia through chloroplast transformation.
Recently, they successfully created a lettuce that can express FIX without antibiotic markers.
Figure 1: Creation of expression vector without resistance marker and transgenic progeny (because the 5'and 3'of the resistance marker expression element can be recombined into a loop, it will be cleared after recombination) The FIX expressed in this lettuce is fused The transport factor CTB (cholera toxin B subunit) can perform protein cleavage and function in the body at the right time.
Due to the use of the optimal chloroplast transformation system and expression vector, the copy number of the FIX-CTB fragment is very high in lettuce leaves, making it possible for stable protein expression in both T1 and T2 generation plants (Figure 1).
After testing, the content of the target protein can reach 1.
0-1.
5 mg per 1 gram of freeze-dried leaves.
Figure 2: The trial and prospect of clinical application of plant cell drug products are further.
They used freeze-dried leaves to feed SD rats, with the content ranging from 0.
25mg/kg to 2.
5mg/kg, and no toxicity and allergic reactions were found.
The feeding experiment of beagle dogs also showed no obvious toxicity and allergic reactions, indicating that taking the plant cells expressing the drugs can effectively avoid allergic reactions caused by the direct use of drugs, and has a great promotion effect on the treatment of hemophilia B ( figure 2).
Original link: https://onlinelibrary.
wiley.
com/doi/epdf/10.
1111/pbi.
13608 Plant Biotechnology Pbj Exchange Group In order to more effectively help the majority of scientific researchers to obtain relevant information, Plant Biotechnology Pbj has established a WeChat Groups, Plant Biotechnology Journal submissions and document-related questions, public account release content and public account submission questions will be concentrated in the group for answers, while encouraging academic exchanges and collision thinking within the group.
In order to ensure a good discussion environment in the group, please add the editor WeChat first, scan the QR code to add, and then we will promptly invite you to join the group.
Tips: When adding the editor WeChat and after joining the group, please be sure to note the school or unit + name, and the PI should be noted at the end, and we will invite you to join the PI group.